Search research articles
Contact Us
Filters
Showing results (351-360 of 434) with videos related to
Page
of 44
Sort By:
Dermatology and Therapy
|
April 18, 2022
Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: Systematic Review and Network Meta-analysis
Jonathan I Silverberg, H Chih-Ho Hong, Jacob P Thyssen, et al.
Dermatology and Therapy
|
July 30, 2024
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials
April W Armstrong, Matthias Augustin, Jennifer L Beaumont, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 22, 2022
A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30<sup>th</sup> EADV Congress 2021
Andreas Pinter, Linda Stein Gold, Adam Reich, et al.
The Journal of Dermatology
|
November 11, 2024
Indirect comparison of deucravacitinib and other systemic treatments for moderate to severe plaque psoriasis in Asian populations: A systematic literature review and network meta-analysis
Tsen-Fang Tsai, Yayoi Tada, Camy Kung, et al.
The Journal of Rheumatology
|
May 3, 2020
Evaluation of Changes in Skin and Joint Outcomes and Associated Treatment Changes in Psoriatic Arthritis (PsA): Experience From the Corrona PsA/SpA Registry
Philip J Mease, Carol J Etzel, William J Huster, et al.
The Journal of Dermatological Treatment
|
August 5, 2021
Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study
Andrew Blauvelt, April W Armstrong, Richard G Langley, et al.
Journal of Drugs in Dermatology : JDD
|
August 2, 2024
Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel
Joshua Burshtein, Milaan Shah, Danny Zakria, et al.
RMD Open
|
June 28, 2019
Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry
Philip J Mease, Carol J Etzel, William J Huster, et al.
Journal of Medical Internet Research
|
September 20, 2021
A Blueprint for the Conduct of Large, Multisite Trials in Telemedicine
Patricia Commiskey, April W Armstrong, Tumaini R Coker, et al.
Journal of Dermatological Science
|
January 23, 2023
Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S study
Andrew Blauvelt, David M Pariser, Stephen Tyring, et al.
Page
of 44
Search research articles
Search
Showing results (351-360 of 434) with videos related to
Sort By:
Page
of 44
Dermatology and Therapy
|
April 18, 2022
Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: Systematic Review and Network Meta-analysis
Jonathan I Silverberg, H Chih-Ho Hong, Jacob P Thyssen, et al.
Dermatology and Therapy
|
July 30, 2024
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials
April W Armstrong, Matthias Augustin, Jennifer L Beaumont, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 22, 2022
A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30<sup>th</sup> EADV Congress 2021
Andreas Pinter, Linda Stein Gold, Adam Reich, et al.
The Journal of Dermatology
|
November 11, 2024
Indirect comparison of deucravacitinib and other systemic treatments for moderate to severe plaque psoriasis in Asian populations: A systematic literature review and network meta-analysis
Tsen-Fang Tsai, Yayoi Tada, Camy Kung, et al.
The Journal of Rheumatology
|
May 3, 2020
Evaluation of Changes in Skin and Joint Outcomes and Associated Treatment Changes in Psoriatic Arthritis (PsA): Experience From the Corrona PsA/SpA Registry
Philip J Mease, Carol J Etzel, William J Huster, et al.
The Journal of Dermatological Treatment
|
August 5, 2021
Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study
Andrew Blauvelt, April W Armstrong, Richard G Langley, et al.
Journal of Drugs in Dermatology : JDD
|
August 2, 2024
Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel
Joshua Burshtein, Milaan Shah, Danny Zakria, et al.
RMD Open
|
June 28, 2019
Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry
Philip J Mease, Carol J Etzel, William J Huster, et al.
Journal of Medical Internet Research
|
September 20, 2021
A Blueprint for the Conduct of Large, Multisite Trials in Telemedicine
Patricia Commiskey, April W Armstrong, Tumaini R Coker, et al.
Journal of Dermatological Science
|
January 23, 2023
Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S study
Andrew Blauvelt, David M Pariser, Stephen Tyring, et al.
Page
of 44